Lopinavir/Ritonavir + Fluticasone/Salmeterol |
7 |
F |
CYP3A4
inhibitors2 may increase the serum concentration of
salmeterol |
Avoid combination or monitor for adverse effects of
salmeterol |
Lopinavir/Ritonavir + Tamsulosin |
4 |
G |
CYP3A4 Inhibitors may
increase the serum concentration of tamsulosin |
Avoid
combination |
Ipratropium Bromide/Salbutamol + Promethazine |
2 |
F |
Increase the
anticholinergic effects |
Avoid combination or monitor for
anticholinergic related toxicity |
Lopinavir/Ritonavir + Midazolam |
2 |
E |
Protease Inhibitors may
increase the serum concentration of midazolam |
Avoid combination or
reduce doses of intravenous midazolam particularly if multiple doses are
used |